From New Schools Venture Fund Offering $7M More To Education Entrepreneurs:

NewSchools Venture Fund CEO Stacey Childress

NewSchools Venture Fund CEO Stacey Childress—

NewSchools Venture Fund CEO Stacey Childress

Underwriters and Partners

Xconomy Insight

Sponsored · Webinar
Applying Cell-based In Vitro Assays to Improve In Vitro Hepatotoxicity Assessment Challenges
In vitro assays that tackle the challenges of in vitro hepatotoxicity assessment
Eurofins Discovery

Sponsored · Webinar
July 21 – The Need for Manufacturing Execution Systems (MES) in Cell and Gene Therapy
A discussion on business drivers, technical considerations, special requirements of cell and gene product manufacturing & digitization strategy
Global OT/IT Quality Services

Sponsored · Whitepaper
Decentralized Clinical Trials: The Call for a New Paradigm
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
PRA Health Sciences

Xconomy on Demand

We offer a number of ways to subscribe for free!